RRRF funding will be used to support Recipients to address the impacts of the COVID-19 pandemic.
ChipCare Corporation
10 enregistrements totalisant 2,437,638.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $1,687,638 | 8 enregistrements |
| Agence fédérale de développement économique pour le Sud de l'Ontario | $750,000 | 2 enregistrements |
Enregistrements
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
RRRF funding will be used to support Recipients to address the impacts of the COVID-19 pandemic.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
Growing evidence suggests that T-cell immunity against the virus is long-lasting and protective against re-infection. ChipCare is investigating a potential assay that will help identify individuals w...
ChipCare is developing a novel point of care platform for the differential diagnosis of infectious diseases. The platform is initially targeted for the North American market. This project is to esta...